Galderma confirms Med-fx as sole-preferred distributor

20 Jun 2019

Pharmaceutical company Galderma (UK) Limited and aesthetic and skincare product supplier Med-fx Ltd will launch new, enhanced packages of customer-centric support services for healthcare professionals who purchase products marketed under the Azzalure and Restylane brands in the UK and Ireland from September 8.

The deal to make Med-fx Galderma’s sole-preferred distributor for its aesthetic portfolio was confirmed on June 20 when the companies signed the contract. 

Galderma has also confirmed that distribution agreements with Church Pharmacy and Wigmore Medical have ended, but both businesses can continue to sell through stock purchased from Galderma prior to September 8 and they both can order further products under Galderma’s standard terms and conditions of sale in the future. 

Toby Cooper, medical solutions business unit head, Galderma UK and Ireland said, “We want to reassure customers that current and future supply of our brands is still available. Product is readily available from usual stockists, but Med-fx is on standby to assist any customers seeking an alternative supplier.”


Log-in to post a comment